3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Breast Neoplasms
15
Carcinoma, Hepatocellular
9
Stomach Neoplasms
8
Rectal Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Neoplasms
6
Neoplasm Metastasis
6
Ovarian Neoplasms
5
Brain Neoplasms
5
Thyroid Neoplasms
4
Sarcoma
4
Recurrence
4
Urinary Bladder Neoplasms
3
Pilonidal Sinus
3
Pancreatic Neoplasms
3
Neoplastic Cells, Circulating
3
Melanoma
3
Lung Neoplasms
3
Kidney Neoplasms
3
Glioblastoma
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Peritoneal Neoplasms
2
Pain, Postoperative
2
Pain
2
Oropharyngeal Neoplasms
2
Oligodendroglioma
2
Liver Neoplasms
2
Gastrointestinal Stromal Tumors
2
Interventions
lutetium Lu 177 dotatate
2
Lutetium-177
2
Liquid Biopsy
2
pentetreotide
1
fluorodopa F 18
1
copper dotatate CU-64
1
Yttrium-90
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Single Photon Emission Computed Tomography Computed Tomography
1
Resveratrol
1
Respiratory Therapy
1
Referral and Consultation
1
Quality of Life
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Palliative Care
1
Nutrition Assessment
1
Needles
1
Magnetic Resonance Spectroscopy
1
Endoscopic Mucosal Resection
1
Diet Therapy
1
Data Collection
1
Cryosurgery
1
Control Groups
1
Colectomy
1
Betaine
1
90Y-octreotide, DOTA-Tyr(3)-
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neuroendocrine Tumors
×
Surgical Procedures, Operative
×
Clear all
NCT03012789
2024-04-30
NETest_Sx
Wren Laboratories LLC
Phase NA
Active not recruiting
40 enrolled